ChromaDex (CDXC) Scheduled to Post Quarterly Earnings on Thursday

ChromaDex (NASDAQ:CDXC - Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Thursday, October 31st. Analysts expect ChromaDex to post earnings of $0.01 per share for the quarter. Investors interested in registering for the company's conference call can do so using this link.

ChromaDex Stock Up 1.2 %

ChromaDex stock traded up $0.04 during midday trading on Friday, reaching $3.47. The stock had a trading volume of 206,833 shares, compared to its average volume of 298,389. The firm has a market capitalization of $262.12 million, a PE ratio of -70.60 and a beta of 1.86. The firm's 50-day moving average price is $3.46 and its 200 day moving average price is $3.24. ChromaDex has a 12 month low of $1.28 and a 12 month high of $4.65.

Insider Activity

In related news, Director Kristin Patrick sold 23,000 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $3.57, for a total value of $82,110.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 9.64% of the company's stock.

Analysts Set New Price Targets

Separately, HC Wainwright reaffirmed a "buy" rating and issued a $6.00 target price on shares of ChromaDex in a research report on Friday, August 9th.

ChromaDex Company Profile

ChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.